Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave ®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Conditions: Obesity Interventions: Drug: Naltrexone-Bupropion (NB) Combination; Drug: Placebo Sponsors: Currax Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bupropion | Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Obesity | Research | Wellbutrin